GB00BSG2DM87 20270610 14.796 News - GG2DM8

Avicanna Subsidiary Completes Export of Aureus Branded CBG into Singapore

This marks the first export into Asia, the 18th international market for Aureus branded products and 21st...

Avicanna Announces Results of Annual General Meeting & Provides Corporate Update

TORONTO, July 10, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX:...

Life Science Virtual Investor Forum Presentations Now Available for Online Viewing

NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor...

Avicanna General Meeting

TORONTO, June 19, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX:...

Avicanna Announces USPTO Issuance of Patent SEDDS Technology

TORONTO, June 19, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF...

Avicanna Reports Q1 2024 and First Positive Adjusted EBIDTA Quarter

Best Quarterly Results in Company’s History from a Financial Perspective.EBITDA Improvements Driven by Record...

Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa

The study conducted at The Hospital for Sick Children evaluated wound healing, pain, and itch.55% of patients...

Avicanna Announces Closing of Non-brokered Private Placement

TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX:...

Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study

TORONTO, April 10, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX:...

Avicanna Reports Full Year 2023 Audited Financial Results

$16.8M in Revenue, representing an increase of 314% from 2022$6.7M Consolidated gross Profit, representing an...

Avicanna Announces the Canadian Launch of 10% CBD (THC Free) Proprietary Formulation

The 10% CBD (THC free) proprietary oral formulation branded as RHO Phyto Micro Drop 100 in Canada RHO Phyto...

Avicanna To Hold Full Year 2023 Earnings Conference Call

TORONTO, March 26, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX:...

ThreeD Capital Inc. Announces New YouTube Channel

TORONTO, March 25, 2024 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK /...

Avicanna Hosts Symposium on Cannabinoid-based Medicine

TORONTO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX:...

Avicanna Announces New Research Collaboration with a Multi-national European-based Pharmaceutical Company

TORONTO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX:...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

GB00BSG2DM87 20270610 14.796 (GG2DM8)

Empower your portfolio: Real-time discussions and actionable trading ideas.

GG2DM8 News

Avicanna Subsidiary Completes Export of Aureus Branded CBG into Singapore

Avicanna Announces Results of Annual General Meeting & Provides Corporate Update

Life Science Virtual Investor Forum Presentations Now Available for Online Viewing

Avicanna General Meeting

Avicanna Announces USPTO Issuance of Patent SEDDS Technology

Avicanna Reports Q1 2024 and First Positive Adjusted EBIDTA Quarter

Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa

Avicanna Announces Closing of Non-brokered Private Placement

Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study

Avicanna Reports Full Year 2023 Audited Financial Results

Avicanna Announces the Canadian Launch of 10% CBD (THC Free) Proprietary Formulation

Avicanna To Hold Full Year 2023 Earnings Conference Call

ThreeD Capital Inc. Announces New YouTube Channel

Avicanna Hosts Symposium on Cannabinoid-based Medicine

Avicanna Announces New Research Collaboration with a Multi-national European-based Pharmaceutical Company

GG2DM8 Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

GB00BSG2DM87 20270610 14.796 (GG2DM8) News

GB00BSG2DM87 20270610 14.796 (GG2DM8)

Empower your portfolio: Real-time discussions and actionable trading ideas.

GG2DM8 News

Avicanna Subsidiary Completes Export of Aureus Branded CBG into Singapore

Avicanna Announces Results of Annual General Meeting & Provides Corporate Update

Life Science Virtual Investor Forum Presentations Now Available for Online Viewing

Avicanna General Meeting

Avicanna Announces USPTO Issuance of Patent SEDDS Technology

Avicanna Reports Q1 2024 and First Positive Adjusted EBIDTA Quarter

Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa

Avicanna Announces Closing of Non-brokered Private Placement

Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study

Avicanna Reports Full Year 2023 Audited Financial Results

Avicanna Announces the Canadian Launch of 10% CBD (THC Free) Proprietary Formulation

Avicanna To Hold Full Year 2023 Earnings Conference Call

ThreeD Capital Inc. Announces New YouTube Channel

Avicanna Hosts Symposium on Cannabinoid-based Medicine

Avicanna Announces New Research Collaboration with a Multi-national European-based Pharmaceutical Company

GG2DM8 Discussion

Your Recent History